Innovative Industrial Properties (IIPR)
NYSE:IIPR
Want to see IIPR full AI Analyst Report?
Top Page
Innovative Industrial Properties
(NYSE:IIPR)
Select Model
Select Model
Rating:73Outperform
Price Target:
$61.00
â–²(15.22% Upside)
Action:Reiterated
Date:05/19/26
IIPR scores well on financial quality (high margins, conservative leverage) and looks attractively valued (low P/E and very high dividend yield). The overall score is held back by weaker recent growth/cash-flow momentum and only mixed technical signals, alongside earnings-call emphasis on refinancing at higher rates and tenant re-tenanting execution risk.
Positive Factors
Conservative Balance Sheet
IIPR’s low leverage and conservative capital mix, plus strong coverage metrics (net debt/adjusted EBITDA ~1.1x and high debt service coverage), provide durable financial flexibility. This supports absorbing tenant volatility, managing maturities, and funding opportunistic acquisitions without forcing distressed asset sales.
Negative Factors
Tenant Credit & Licensing Risk
Concentration in licensed cannabis operators exposes IIPR to operator credit stress and licensing delays. Defaults force legal action and retenanting, with new leases often subject to licensing and diligence, extending vacancy and creating earnings uncertainty until replacements fully stabilize rents and cash collection.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
IIPR’s low leverage and conservative capital mix, plus strong coverage metrics (net debt/adjusted EBITDA ~1.1x and high debt service coverage), provide durable financial flexibility. This supports absorbing tenant volatility, managing maturities, and funding opportunistic acquisitions without forcing distressed asset sales.
Read all positive factors
Innovative Industrial Properties Key Performance Indicators (KPIs)
Any
Rentable Space
Measures the total square footage available for leasing, indicating potential revenue growth and capacity to expand tenant relationships.
Measures the total square footage available for leasing, indicating potential revenue growth and capacity to expand tenant relationships.
Data provided by:
The Fly
The FlyInnovative Industrial Properties (IIPR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.55B
Dividend Yield13.07%
Average Volume (3M)354.43K
Price to Earnings (P/E)10.7
Beta (1Y)0.73
Revenue Growth-13.63%
EPS Growth-24.40%
CountryUS
Employees21
SectorReal Estate
Sector Strength53
IndustryREIT - Industrial
Share Statistics
EPS (TTM)4.03
Shares Outstanding28,774,470
10 Day Avg. Volume386,482
30 Day Avg. Volume354,428
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)0.72
Price to Sales (P/S)4.99
P/FCF Ratio7.59
Enterprise Value/Market Cap1.19
Enterprise Value/Revenue7.02
Enterprise Value/Gross Profit11.65
Enterprise Value/Ebitda8.54
Forecast
1Y Price Target
$58.75Price Target Upside10.97% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)4.32
Revenue Forecast (FY)$268.23M
Innovative Industrial Properties Business Overview & Revenue Model
Company Description
Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated medical-use cannabis f...
How the Company Makes Money
IIPR makes money primarily by generating rental revenue from leasing its owned properties to state-licensed cannabis operators. Its core model is to invest in cannabis-related industrial real estate (often cultivation and processing facilities) an...
Innovative Industrial Properties Earnings Call Summary
Earnings Call Date:May 04, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 05, 2026
Earnings Call Sentiment Positive
The call depicts a company in stabilization and active execution mode: revenue and AFFO were stable with modest revenue growth (+3.5%), substantial leasing activity and portfolio re‑tenants underway, meaningful capital raising ($128M) and strong liquidity/credit metrics. Offsetting these positives are near-term refinancing needs, higher financing costs (term loan at 9% and prospective financings ~8%+), legacy tenant defaults requiring retenanting and conditional LOIs subject to licensing and diligence. Regulatory progress (medical rescheduling) is material and positive for operator economics, but important banking/interstate-commerce issues remain unresolved. Overall the company is making clear operational progress while managing elevated financing and transitional asset risks.Positive Updates
Revenue Growth
Total revenues of $69.0 million in Q1 2026, a 3.5% increase compared to Q4 2025, driven primarily by payments from PharmaCann and settlement receipts.
Negative Updates
Near-Term Unsecured Bond Maturity and Refinancing Risk
An unsecured bond maturity in the month required active capital raising; while $128M has been raised and nearly $130M of additional financings are in process (including a $56.5M financing at 8.75%), these transactions remain subject to contingencies and are not guaranteed to close on current terms.
Read all updates
Q1-2026 Updates
Positive
Negative
Revenue Growth
Total revenues of $69.0 million in Q1 2026, a 3.5% increase compared to Q4 2025, driven primarily by payments from PharmaCann and settlement receipts.
Read all positive updates
Company Guidance
On the call management reiterated disciplined capital and portfolio guidance: year-to-date they have raised $128 million (comprised of $72M preferred equity, $36M common equity and $20M secured debt) and are pursuing nearly $130M more in secured/unsecured financings (including a $56.5M facility at 8.75% expected to fund today and a recently closed $20M 3‑year secured term loan at 9%), targeting a blended cost just over 8% to address an unsecured bond maturity this month and fund growth; Q1 results were total revenues of $69M (up 3.5% QoQ) and AFFO of $53.4M or $1.88 per share (flat QoQ), with $3.2M from PharmaCann and a $1.5M Gold Flora settlement contributing, liquidity of ~$177M ($89M cash, $87.5M revolver availability), debt service coverage >11x and net debt/adjusted EBITDA of 1.1x; leasing and portfolio actions included ~331k SF of new leases in the quarter (389k SF YTD across 5 properties), all 3 Gold Flora assets (330k SF) now leased, tentative agreements on ~488k SF of 4Front assets, executed PharmaCann leases of 66k SF (Dwight, IL) and 58k SF (OH) plus a 234k SF NY LOI and other negotiations, and life‑science exposure with $175M funded of a $270M IQHQ commitment (remaining $95M expected over time) in investments averaging north of 14% yield vs ~6% cost of capital.Innovative Industrial Properties Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
82
Very Positive
Cash Flow
67
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 263.23M | 265.95M | 308.52M | 309.51M | 276.36M | 204.55M |
| Gross Profit | 158.61M | 235.78M | 280.05M | 284.61M | 265.84M | 200.11M |
| EBITDA | 216.37M | 208.70M | 248.72M | 248.88M | 232.64M | 172.15M |
| Net Income | 119.98M | 114.44M | 161.66M | 165.59M | 154.39M | 113.99M |
Balance Sheet | ||||||
| Total Assets | 2.39B | 2.37B | 2.38B | 2.39B | 2.41B | 2.08B |
| Cash, Cash Equivalents and Short-Term Investments | 89.12M | 47.60M | 146.25M | 140.25M | 87.12M | 81.10M |
| Total Debt | 365.98M | 393.70M | 297.87M | 300.88M | 301.50M | 326.09M |
| Total Liabilities | 499.44M | 522.85M | 441.99M | 438.12M | 452.94M | 472.90M |
| Stockholders Equity | 1.89B | 1.85B | 1.94B | 1.95B | 1.96B | 1.61B |
Cash Flow | ||||||
| Free Cash Flow | 197.03M | 174.76M | 258.45M | 255.54M | -139.75M | 188.75M |
| Operating Cash Flow | 199.98M | 198.19M | 258.45M | 255.54M | 234.13M | 188.75M |
| Investing Cash Flow | -157.49M | -174.30M | -56.00M | -6.79M | -396.20M | -384.09M |
| Financing Cash Flow | -81.39M | -122.54M | -197.90M | -195.63M | 164.22M | 155.76M |
Innovative Industrial Properties Technical Analysis
Neutral
52.94
Price Trends
52.58
Positive
50.10
Positive
49.22
Positive
Market Momentum
0.78
Positive
50.74
Neutral
15.61
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IIPR, the sentiment is Neutral. The current price of 52.94 is below the 20-day moving average (MA) of 55.34, above the 50-day MA of 52.58, and above the 200-day MA of 49.22, indicating a neutral trend. The MACD of 0.78 indicates Positive momentum. The RSI at 50.74 is Neutral, neither overbought nor oversold. The STOCH value of 15.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IIPR.
Innovative Industrial Properties Risk Analysis
Innovative Industrial Properties disclosed 84 risk factors in its most recent earnings report. Innovative Industrial Properties reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Innovative Industrial Properties Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $8.33B | 13.39 | 12.77% | 2.98% | 8.82% | 28.07% | |
73 Outperform | $1.55B | 10.70 | 6.41% | 13.07% | -13.63% | -24.40% | |
71 Outperform | $7.22B | 27.77 | 6.95% | 4.02% | 9.98% | -2.19% | |
67 Neutral | $3.00B | -2,814.46 | 4.61% | 5.33% | -3.81% | 52.53% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
55 Neutral | $523.99M | -9.97 | -10.91% | 2.20% | 2.57% | 42.59% |
* Real Estate Sector Average
IIPR
Innovative Industrial Properties
54.58
5.32
10.79%
STAG
Stag Industrial
38.19
3.70
10.74%
FR
First Industrial Realty
61.52
12.30
24.98%
LXP
LXP Industrial Trust
51.50
11.92
30.10%
ILPT
Industrial Logistics Properties
8.10
4.77
143.17%
Innovative Industrial Properties Corporate Events
Business Operations and StrategyPrivate Placements and Financing
Innovative Industrial Properties Secures New Long-Term Term Loans
Positive
May 19, 2026
On May 18, 2026, Innovative Industrial Properties’ indirect subsidiaries IIP-MA 7 LLC and IIP-PA 6 LLC entered into separate loan agreements with Amalgamated Bank for a combined $22.9 million in secured term loans, split between a $10.5 mill...
Business Operations and StrategyPrivate Placements and Financing
Innovative Industrial Properties Secures $56.5 Million Term Loan
Positive
May 6, 2026
On May 5, 2026, several indirect subsidiaries of Innovative Industrial Properties entered into a loan agreement for a $56.5 million secured term loan maturing May 5, 2029, with interest set at one‑month SOFR plus 5.00%. The loan is jointly a...
Business Operations and StrategyDividendsFinancial DisclosuresLegal ProceedingsPrivate Placements and Financing
Innovative Industrial Properties Reports Strong Q1 2026 Results
Positive
May 4, 2026
Innovative Industrial Properties, Inc. reported first-quarter 2026 results on May 4, 2026, posting total revenue of $69 million, net income attributable to common stockholders of $30.2 million, or $1.02 per diluted share, and AFFO of $53.4 million...
Business Operations and StrategyPrivate Placements and Financing
Innovative Industrial Properties Adds New Secured Term Loan
Positive
Apr 29, 2026
On April 24, 2026, an indirect subsidiary of Innovative Industrial Properties, Inc., IIP-IL 2 LLC, issued a promissory note for a $20 million secured term loan with Generations Bank, bearing a fixed interest rate of 9.00% and maturing on April 22,...
Business Operations and StrategyExecutive/Board Changes
Innovative Industrial Properties Announces Planned Board Leadership Transition
Neutral
Apr 10, 2026
On April 6, 2026, Innovative Industrial Properties, Inc. announced that director Gary Kreitzer will retire from its board and will not stand for re-election when his term expires at the 2026 annual meeting of shareholders. The company emphasized t...
Business Operations and StrategyLegal Proceedings
Innovative Industrial Resolves Tenant Disputes, Advances Retenanting Strategy
Neutral
Mar 16, 2026
Innovative Industrial Properties announced on March 16, 2026 that it has resolved all pending litigation with PharmaCann Inc. over prior lease defaults, securing monetary judgments and agreed turnover of three properties in New York, Ohio and Penn...
Business Operations and StrategyStock Buyback
Innovative Industrial Properties Announces New $100M Buyback Program
Positive
Mar 4, 2026
On March 3, 2026, Innovative Industrial Properties, Inc. approved a new share repurchase program authorizing the buyback of up to $100 million of its common stock, replacing its existing plan that was set to expire on March 17, 2026. The program, ...
Business Operations and StrategyDividendsFinancial DisclosuresPrivate Placements and Financing
Innovative Industrial Properties Reports 2025 Results, Grows Dividend
Positive
Feb 23, 2026
On February 23, 2026, Innovative Industrial Properties reported full-year 2025 revenues of $266.0 million, net income attributable to common stockholders of $114.4 million, and AFFO of $205.4 million, while continuing its track record of annual di...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.